TNF Alpha Protein

📖 Wiki Page

protein1063 wordssynced 2026-04-02

TNF Alpha Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TNF Alpha Protein</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TNF</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Tumor Necrosis Factor Alpha</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P01375</td>
</tr>
<tr>
<td class="label">Length</td>
<td>233 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>25.6 kDa (monomer), 52.4 kDa (trimer)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6p21.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7124</td>
</tr>
<tr>
<td class="label">Cellular Localization</td>
<td>Secreted (type II transmembrane protein)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TNF Superfamily</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TNFRSF1A (TNFR1)</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">TNFRSF1B (TNFR2)</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">TNFRSF1B</td>
<td>Decoy receptor</td>
</tr>
<tr>
<td class="label">TRADD</td>
<td>Adapter protein</td>
</tr>
<tr>
<td class="label">RIPK1</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">TRAF2</td>
<td>Adapter protein</td>
</tr>
<tr>
<td class="label">CASP8</td>
<td>Protease</td>
</tr

...

TNF Alpha Protein

Introduction

Tumor necrosis factor alpha (TNF-α) is a potent pro-inflammatory cytokine that plays a central role in immune regulation, inflammation, and cell survival. As a member of the TNF superfamily, TNF-α is produced primarily by activated macrophages and monocytes, but also by [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), and [neurons](/entities/neurons) in the central nervous system. TNF-α signals through two distinct receptors—TNFR1 (p55) and TNFR2 (p75)—which activate both pro-inflammatory [NF-κB](/entities/nf-kb) signaling and caspase-dependent [apoptosis](/entities/apoptosis) pathways. In neurodegeneration, TNF-α is a key mediator of chronic neuroinflammation, driving disease progression in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and traumatic brain injury.

Overview

TNF-α is synthesized as a 26 kDa type II transmembrane protein that can be shed as a soluble 17 kDa trimer by proteolytic cleavage (TACE/ADAM17). The soluble trimer is the biologically active form that engages TNF receptors with high affinity (Kd ~ 10^-10 M).

Structure

TNF-α adopts a classic β-jelly roll fold characteristic of the TNF family:

Trimeric assembly: Functional unit is a stable trimer
β-sandwich fold: Two β-sheets forming a jelly roll topology
Receptor binding sites: Three receptor binding sites per trimer

Structural Features

Membrane-bound form: Type II transmembrane protein with extracellular domain

Soluble form: Proteolytically cleaved by TACE/ADAM17

Receptor interfaces: Each trimer binds up to three receptor molecules

Crystallographic structure: Reveals symmetric trimeric assembly

Normal Function

Immune System

TNF-α is a master regulator of inflammation:

Pro-inflammatory signaling: Activates NF-κB and MAPK pathways
Cell death: Induces apoptosis through caspase-8 activation
Fever generation: Acts on hypothalamus via prostaglandin production
Cachexia: Promotes muscle wasting in chronic disease
Leukocyte recruitment: Induces adhesion molecule expression

Nervous System

In the CNS, TNF-α has complex and context-dependent effects:

Synaptic plasticity: Modulates glutamatergic signaling and [LTP](/mechanisms/long-term-potentiation)
Glial activation: Induces astrocyte and microglial inflammatory responses
[Blood-brain barrier](/entities/blood-brain-barrier): Regulates BBB permeability
Pain modulation: Sensitizes pain pathways
Neuroprotection: At low levels, can activate survival pathways

Signaling Pathways

TNF-α activates three major signaling cascades:

NF-κB pathway: Pro-inflammatory gene activation via IKK complex

MAPK pathways: p38, JNK, ERK regulate stress and inflammation

Caspase pathway: Apoptosis through caspase-8 activation

Role in Disease

Alzheimer's Disease

TNF-α is a central driver of neuroinflammation in AD:

Elevated levels: Increased in AD brain, CSF, and plasma
Plaque interaction: Associates with amyloid plaques
Synaptic dysfunction: Disrupts synaptic plasticity and memory
Neuronal death: Promotes excitotoxic and apoptotic pathways
Therapeutic target: Primary candidate for anti-inflammatory therapy

Parkinson's Disease

In PD, TNF-α mediates dopaminergic degeneration:

Substantia nigra elevation: High expression in PD brains
Microglial activation: Sustains chronic neuroinflammation
Dopaminergic toxicity: Direct and indirect neuronal damage
[Alpha-synuclein](/proteins/alpha-synuclein): Modulates aggregation and spread
Genetic links: TNF polymorphisms associated with PD risk

Amyotrophic Lateral Sclerosis

TNF-α contributes to motor neuron degeneration:

Systemic elevation: Increased in ALS patients
Motor [cortex](/brain-regions/cortex) involvement: High expression in affected regions
Glial contribution: Microglial and astrocytic sources
Disease progression: Correlates with progression rate

Multiple Sclerosis

Central role in demyelination and lesion formation:

Demyelination: Promotes oligodendrocyte death
BBB disruption: Increases vascular permeability
Lesion activity: Accumulates in active MS lesions
Relapse: Correlates with clinical activity

Traumatic Brain Injury

Secondary damage: Exacerbates post-injury neurodegeneration
Excitotoxicity: Amplifies glutamate-induced damage

Therapeutic Targeting

TNF-α is a major drug target with several approved therapies:

Approved Therapies

TNF Inhibitors (Biologics)

Etanercept (Enbrel): TNF receptor-Fc fusion protein
Infliximab (Remicade): Anti-TNF monoclonal antibody
Adalimumab (Humira): Anti-TNF monoclonal antibody
Certolizumab pegol (Cimzia): PEGylated Fab fragment
Golimumab (Simponi): Anti-TNF monoclonal antibody

Challenges in Neurology

Blood-brain barrier: TNF inhibitors don't effectively cross BBB
CNS delivery strategies: Focused ultrasound, intrathecal administration
Peripheral vs CNS: Differentiating peripheral vs CNS TNF effects

Biomarker Potential

TNF-α serves as a biomarker for neuroinflammation:

CSF TNF-α: Elevated in AD, PD, ALS, MS
Plasma/serum: Peripheral marker of systemic inflammation
Therapeutic monitoring: Tracks anti-inflammatory treatment response

Interaction Network

Key Publications

PMID: 18628599(https://pubmed.ncbi.nlm.nih.gov/18628599/) - TNF therapy: clinical applications

PMID: 17051405(https://pubmed.ncbi.nlm.nih.gov/17051405/) - TNF in neurodegeneration

PMID: 20153736(https://pubmed.ncbi.nlm.nih.gov/20153736/) - TNF signaling in the brain

PMID: 17640134(https://pubmed.ncbi.nlm.nih.gov/17640134/) - TNF and inflammatory disease

PMID: 24361397(https://pubmed.ncbi.nlm.nih.gov/24361397/) - TNF in synaptic function

PMID: 25997342(https://pubmed.ncbi.nlm.nih.gov/25997342/) - Neuroinflammation mechanisms

PMID: 26437361(https://pubmed.ncbi.nlm.nih.gov/26437361/) - Cytokines in neurodegeneration

PMID: 28739464(https://pubmed.ncbi.nlm.nih.gov/28739464/) - IL-1β and neuroinflammation

PMID: 26245252(https://pubmed.ncbi.nlm.nih.gov/26245252/) - TNF-alpha in brain disease

PMID: 28942321(https://pubmed.ncbi.nlm.nih.gov/28942321/) - IL-6 and Parkinson's disease

Pathway & Interaction Diagram

Interactive diagram showing TNF's key relationships in the SciDEX knowledge graph (15 connections shown).

Mermaid diagram (expand to render)

External Links

[UniProt P01375](https://www.uniprot.org/uniprot/P01375)
[NCBI Gene 7124](https://www.ncbi.nlm.nih.gov/gene/7124)
[Human Protein Atlas](https://www.proteinatlas.org/ENSG00000228390-TNF)
[KEGG Pathway: TNF signaling](https://www.kegg.jp/kegg-bin/show_pathway?map04668)

Background

The study of Tnf Alpha Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Tracey D, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18628599/)

[McCoy MK, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/17051405/)

[Cheng J, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20153736/)

[Clark IA, et al, (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17640134/)

[Olmos G, et al, (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24361397/)

[Lyman M, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/25997342/)

[Smith JA, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/26437361/)

[Rai SN, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/28942321/)

[Guo S, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/26245252/)

[Rothaug M, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27091020/)

📖 View canonical wiki page →

TNF Alpha Protein

TNF Alpha Protein

Introduction

TNF Alpha Protein

Introduction

Overview

Structure

Structural Features

Normal Function

Immune System

Nervous System

Signaling Pathways

Role in Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Multiple Sclerosis

Traumatic Brain Injury

Therapeutic Targeting

Approved Therapies

Challenges in Neurology

Biomarker Potential

Interaction Network

Key Publications

Pathway & Interaction Diagram

See Also

External Links

Background

References